Oral Itraconazole for Treatment of Infantile Hemangiomas: Updated Clinical and Mechanism Research |
Conferences
eMediNexus Coverage from: 
Oral Itraconazole for Treatment of Infantile Hemangiomas: Updated Clinical and Mechanism Research
Dr Yuping Ran, Chenglu, China,  23 January 2019
Coronavirus Live Count Map India

remove_red_eye 735 Views
COVID-19 Vaccine Updates

Coronavirus Protocols

#Dermatology

0 Read Comments                

The clinical efficacy of oral itraconazole is 71.05%.It may cause mild, reversible diarrhea.Down regulation of P13-AKT-mTOR and Hedgehog signalling pathways, inhibition of hemangioma cell growth.Induces hemangioma endothelial cells autophagy and apoptosis....
To read the complete article ,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now